Cargando…

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082859/ https://www.ncbi.nlm.nih.gov/pubmed/27789534 http://dx.doi.org/10.1136/bmj.i5782

Ejemplares similares

“A lot can happen in five years”: Women's attitudes to extending cervical screening intervals
por: Kola‐Palmer, Susanna, et al.
Publicado: (2022)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review
por: Taylor-Phillips, Sian, et al.
Publicado: (2016)

Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study
por: Hill, Emily, et al.
Publicado: (2020)

Testing key messages about extending cervical screening intervals
por: A.V. Marlow, Laura, et al.
Publicado: (2022)

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
por: Looker, H. C., et al.
Publicado: (2013)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England
por: Nemec, Martin, et al.
Publicado: (2022)

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
por: Rebolj, Matejka, et al.
Publicado: (2022)

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021)

Women's perspectives on human papillomavirus self‐sampling in the context of the UK cervical screening programme
por: Williams, Denitza, et al.
Publicado: (2017)

Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences
por: Chen, Y-Y, et al.
Publicado: (2009)

The occurrence of interval cancers in the Nijmegen screening programme.
por: Peeters, P. H., et al.
Publicado: (1989)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
por: Marchadier, Agathe, et al.
Publicado: (2023)

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
por: Miller, Anthony B, et al.
Publicado: (2014)

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation
por: van den Broek, Ingrid V F, et al.
Publicado: (2012)

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
por: Wai, E S, et al.
Publicado: (2005)

Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea
por: Lee, Hyunju, et al.
Publicado: (2019)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme
por: Gill, M D, et al.
Publicado: (2012)

Interval cancers in the Dutch breast cancer screening programme
por: Fracheboud, J, et al.
Publicado: (1999)

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
por: Sherlaw-Johnson, C, et al.
Publicado: (2004)

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study
por: Jansen, EEL, et al.
Publicado: (2020)

Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening
por: Huang, Y-K, et al.
Publicado: (2008)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

Radiological review of interval cancers in an Australian mammographic screening programme
por: Cawson, J, et al.
Publicado: (2000)

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
por: Creighton, Prudence, et al.
Publicado: (2010)

Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy
por: Viiala, Charlie Henri, et al.
Publicado: (2008)

Effectiveness of a small breast screening programme: 25 year evaluation (25 year breast screening evaluation)
por: Nisbet, Andrew Patric, et al.
Publicado: (2019)

Randomised prostate cancer screening trial: 20 year follow-up
por: Sandblom, Gabriel, et al.
Publicado: (2011)

Self‐sampling as the principal modality for population based cervical screening: Five‐year follow‐up of the PaVDaG study
por: Stanczuk, Grazyna A., et al.
Publicado: (2021)

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2008)

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme
por: Enerly, Espen, et al.
Publicado: (2016)

Telepathology in cervical and breast cancer screening programmes
por: Colombari, Romano, et al.
Publicado: (2013)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands
por: van Hulst, Marinus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tq6ka91m237gmipt5p5vg64f2t